WELCOME TO MIOCA
Established in 2011, the Michigan Ovarian Cancer Alliance strives to save the lives of women and girls by promoting the early detection of ovarian cancer and improved treatment outcomes. MIOCA raises awareness of ovarian cancer, provides resources and support to survivors and their families, advocates both locally and federally, educates Michigan communities, and funds innovative ovarian cancer research.
MIOCA in the news
Join us in welcoming two new staff members at the Michigan Ovarian Cancer Alliance (“MIOCA”)
Emily Haan joins MIOCA as a Special Events Manager and will work to expand the philanthropic support of MIOCA through its many fundraising and awareness events.
Michigan Ovarian Cancer Alliance Announces New Staff Members
Join us in welcoming two new staff members at the Michigan Ovarian Cancer Alliance (“MIOCA”).
Beth Anderson joins MIOCA as a part-time Administrative Coordinator to coordinate the administrative and fundraising functions of MIOCA by supporting the Executive Director, staff and volunteers.
Patty Aldrich joins MIOCA as a part-time Accountant to support the financial and accounting operations by working with the Executive Director, Board Treasurer and staff.
Michigan Ovarian Cancer Alliance Appoints New Executive Director
The board of directors at the Ann Arbor-based, non-profit Michigan Ovarian Cancer Alliance (“MIOCA”) appointed Mary Lynn Faunda Donovan as its new full-time executive director. She succeeds Amy Milanovich who stepped down after serving in a part-time capacity in 2019.
MIOCA Makes $150,000 available to Ovarian Cancer Researchers in Michigan
2020 Geri Fournier Research Grant Application
MIOCA has released the application for the 2020 Geri Fournier Research Grants. Through this grant program, MIOCA supports researchers within the state of Michigan who are conducting important work to improve the quality of lives and treatment for women with ovarian cancer. In 2019, MIOCA reached an important milestone in its effort to save lives. Since it started giving grants in 2014, MIOCA has now awarded over a half-million dollars to researchers in Michigan who are finding new ways to improve the early detection and treatment of ovarian cancer. “Each and every research project we fund has the potential to result in improved understanding of the disease that will hopefully transform lives for women across Michigan and beyond,” said Pam Dahlmann, MIOCA Co-Founder and President. The award, named for Pam’s mother who helped establish MIOCA before her death from ovarian cancer in 2011, was created to recognize the critical research happening right here, in our state, which is often underfunded.
Bring Tie Michigan Teal to Your Town!
MIOCA is looking for enthusiastic people who would like to help bring awareness of ovarian cancer to cities throughout the state during our “Tie Michigan Teal” campaign!
We celebrate National Ovarian Cancer Awareness Month in September by tying teal ribbons around lamp posts in downtown areas, as well as by hanging posters which list the symptoms of ovarian cancer. We need coordinators to oversee the effort in various cities/towns, including Ann Arbor, and across the state. We provide all of the materials and directions for tying the ribbons.
If you would like to learn more about how you can get involved and “teal” your city or even your personal property/workplace, please contact MicheleGatti
. Imagination and creativity is welcome as not every city is a prime location for “tealing,” however there are other ways to get awareness out with the teal ribbons.
MIOCA releases it's 2018 Annual Report
We are proud to present MIOCA’s 2018 Annual Report
, highlighting another year of continued success as we move the needle to improve the health and quality of life for women and girls with ovarian cancer. As you will see in these pages, again this year MIOCA provided critical support to ovarian cancer survivors and their families directly, while working closely with the scientific, medical, and legislative communities to improve treatment and early detection of ovarian cancer.